Advances in drug delivery to the posterior segment

Advances in drug delivery to the posterior segment.

PURPOSE OF REVIEW Emerging developments and research for drug delivery to the posterior segment offer a promising future for the treatment of vitreoretinal disease. As new technologies enter the market, clinicians should be aware of new indications and ongoing clinical trials. RECENT FINDINGS This review summarizes the advantages and shortcomings of the most commonly used drug delivery method...

Advances in Targeted Drug Delivery

Advances in Targeted Drug Delivery

Ocular Drug Delivery: Targeting the Posterior Segment

An inch or less. That is the short distance an ocular drug must travel to reach a target site at the back of the eye. Research has traveled a long way over the past 4 decades in efforts to make this inch-long journey more successful. Delivering ocular drugs to their target tissues often requires them to traverse the fatwater-fat structure of the corneal barrier, while ensuring minimum wastage t...

Ocular Drug Delivery: Targeting the Posterior Segment

One inch or less. That is the short distance an ocular drug must travel to reach a target site at the back of the eye. Research has come a long way over the past 4 decades in efforts to make this inch-long journey more successful. Delivering ocular drugs to their target tissues often requires them to traverse the fat-water-fat structure of the corneal barrier while ensuring minimum wastage thro...